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RESPONSIVENESS OF LATERAL COMPARTMENT JOINT SPACE WIDTH:
DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI)
R.L. Russell y, J. Lynch z, M. Nevitt z, J. Duryea y. yBrigham and Women’s
Hosp., Boston, MA, USA; zUniv. of California San Francisco, San
Francisco, CA, USA
Purpose: An important structural measure of OA progression is radio-
graphic joint space width (JSW). Although a substantial fraction of
knees have lateral compartment OA, this compartment is much less
studied. As an example, the knee radiographs for the OAI were acquired
with a protocol designed for the medial compartment, therefore
measurements of lateral compartment JSW are potentially less reliable.
Furthermore, JSW measurement covering the full extent of the lateral
compartment could not be made for a substantial fraction of the knees
due to sub optimal positioning for the lateral compartment. Previous
work has conﬁrmed themost responsive location tomeasure JSW in the
medial compartment as a function of x, a dimensionless variable
derived from an anatomical coordinate system. An analogous location
in the lateral compartment has not been determined, and currently
lateral compartment JSW readings for the OAI have been deemed
“experimental”. The goal of this project was to determine the most
responsive locations in the lateral compartment to measure JSW loss in
patients with lateral compartment disease.
Methods: We selected all patients from the OAI with knee radiographs
available for the baseline (BL) and 48 month visits, BL Kellgren Law-
rence score of 2 or 3, and greater joint space narrowing in the lateral
compartment than the medial compartment based on the OARSI JSN
score. Exclusion criteria were the presence of TKR and inconsistent
positioning of the knee as determined by the tibial alignment (OAI
variable TPCFDS), a measure of the distance between the projected tibia
rim and plateau. A change of greater than 2mm was grounds for
exclusion. These criteria provided 326 knees from 278 unique IDs.
Results: Complete coverage of the tibial plateau (deﬁned as x¼ 0.700 to
0.900) was available for 283 out of 326 knees (86%). A secondary
analysis was performed including knees (N ¼ 300, 92%) with partial
coverage (deﬁned as x ¼ 0.700 to 0.775). (Row 5 of the table) The
location x ¼ 0.725 provided the most responsive measure of JSW for all
groups, but the responsiveness was substantially uniform from x ¼
0.700 to x ¼ 0.775.
Conclusions: In patients with lateral OA we found that the most
responsive measure of JSW was in the inner portion of the compart-
ment (between x¼ 0.700 and x¼ 0.775) as measured by the SRM value.
In this range there was little variation in SRM value, so each location
provides a comparably responsive measure. An examination of the two
SRM components revealed that improved performance in the x ¼ 0.700
to x ¼ 0.775 was due to a reduced standard deviation rather than
increased joint space loss. This suggests that this region provides a more
reliable measurement rather than reﬂecting more change. This study
marks a step toward understanding the best way to measure JSW in
patients with lateral compartment knee OA.Table. SRM values at ﬁxed locations (x) along lateral compartment of the knee. N/A corresponds to missing values due to lack of coverage for all knees
x ¼ 0.700 x ¼ 0.725 x ¼ 0.750 x ¼ 0.775 x ¼ 0.800 x ¼ 0.825 x ¼ 0.850 x ¼ 0.875 x ¼ 0.900
All (N ¼ 283) -0.99 -1.06 -1.03 -0.98 -0.95 -0.90 -0.86 -0.83 -0.85
KL2 (N ¼ 157) -0.94 -0.99 -0.95 -0.87 -0.83 -0.80 -0.79 -0.79 -0.81
KL3 (N ¼ 12 6) -1.06 -1.16 -1.14 -1.15 -1.14 -1.07 -0.96 -0.90 -0.91
Including partial (N ¼ 300) -0.94 -1.00 -0.97 -0.92 N/A N/A N/A N/A N/A100
COMPREHENSIVE PROTEIN PROFILING OF SYNOVIAL FLUID IN
OSTEOARTHRITIS
M.J. Peffers y, B.T. McDermott y, C.M. Riggs z, P.D. Clegg y. yUniv. of
Liverpool, Neston, United Kingdom; zVet. Clinical Services of the Hong
Kong Jockey Club, Hong Kong, Hong Kong
Purpose: In order to understand the pathophysiology of osteoarthritis
(OA) its mediators need to be identiﬁed. Synovial ﬂuid (SF) is a joint
located serum ﬁltrate with additional contributions from articularcartilage, synovium and bone. It represents a potential source of dis-
ease speciﬁc proteins that could aid in the understanding of the
pathogenesis of joint disease and be used in the early diagnosis of
disease. Mass spectrometry (MS) provides opportunities to discover
disease mechanisms whilst simultaneously identifying potential bio-
markers of OA. In MS high abundance proteins interfere with the
signal from low abundance proteins; the fraction containing most
potential proteins of interest. To overcome this methods of protein
depletion or equalisation have been used. However in SF proteomics
only protein depletion using expensive immunodepletion columns
has been implemented. We therefore investigated the use of a more
cost effective equalisation method using Proteominer beads in order
to comprehensively proﬁle the protein complement of SF in health and
OA using liquid chromatography mass spectrometry (LC-MS/MS).
Additionally label-free quantiﬁcation identiﬁed potential OA
biomarkers.
Methods: Following the collection of SF from the meta-
carpophalangeal joints of 9 normal and 9 OA racing thoroughbred
horses macroscopic, microscopic and synovitis scoring was under-
taken. SF was hyaluronidase treated and high abundant proteins
depleted using ProteoMiner equalisation beads. Reduction, alkyla-
tion and trypsin digestion were undertaken directly on the beads after
equal protein loading. To investigate the efﬁciency of ProteoMiner
technology a single SF sample was analysed without protein depletion.
All samples were individually analysed on a two hour gradient with
LC-MS/MS using a NanoAcquity LC coupled to a LTQ Orbitrap Velos.
Progenesis LC-MS software was used for label-free quantiﬁcation
with data searched for protein identiﬁcations using Mascot in the
Ensembl database for horse. To maximise the number of quantiﬁable
protein with an acceptable false discovery rate (FDR) the peptide
matches were adjusted to 1% FDR prior to the protein identiﬁcations
being re-imported into Progenesis. Adjusted ANOVA values of
p<0.05 and additionally regulation of >2-fold were regarded as
signiﬁcant.
Results: The average modiﬁed Mankins score, palmar osteochondral
disease score and synovitis scores for normal samples were 0.8 0.35, 0
and 1.1  0.2 and OA samples were 13.6  1.4, 1.7  0.2, 2.3  0.2 (mean
 standard error mean). The number of protein identiﬁcations was
increased by 33% in the Proteominer treated SF compared to unde-
pleted SF. Following Proteominer treatment and Progenesis analysis
a total of 754 proteins were identiﬁed in SF, 593 with a signiﬁcant
Mascot score. Thus Proteominer beads concentrated the lower
abundance proteins enabling the most comprehensive SF proteome to
date. Proteins identiﬁed included those relating to matrix proteins,
inﬂammatory factors, complement activation proteins and proteases. A
subset of 10 proteins were identiﬁed which were differentially
expressed in OA SF (Table 1).
Conclusions: A number of proteins were identiﬁed for the ﬁrst time
in SF which may be involved in the pathogenesis of OA. We identiﬁed
a distinct set of proteins that may act as potential biomarkers to
distinguish between normal and OA joints. S100-A10, a calciumbinding protein has upregulated in OA. Other S100 proteins have
been demonstrated as having a role in the pathogenesis of OA and in
SF proteomic studies. However this is the ﬁrst time S100-A10 has
been implicated in OA. Together with its binding partner annexin 2 it
acts as a plasminogen receptor and regulates plasminogen-depend-
ant macrophage activation. This may have a role in the synthesis and
activation of matrix degrading proteases. CD109 is a TGF-b co-
receptor, released from the chondrocyte cell surface that inhibits
TGF-b signalling. Its contribution to the disregulation of TGF-b is
unknown.
Proteins differentially expressed in OA SF identiﬁed with gretare than 2 fold
change and P<0.05
Protein Anova
(p)
Maximum
fold change
Highest mean
condition
S100-A10 0.00028 2.2 OA
CD109 antigen 0.00039 2.0 OA
Phospholipid transfer protein
isoform 1
0.00098 2.7 OA
Complement component C8
gamma chain
0.0115 3.1 OA
Collagen alpha-1(I) chain 0.0459 2.8 OA
Calsyntenin-1 0.0485 2.1 OA
Integral membrane protein 2B 0.00068 2.1 Normal
mannan-binding lectin serine
protease 2
0.0061 2.2 Normal
Keratin, type II cytoskeletal 7 0.0114 2.2 Normal
Cyclin D binding myb-like
transcription factor 1
0.0240 6.2 Normal
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SERUM BIOCHEMICAL MARKERS OF JOINT METABOLISM AND
INFLAMMATION IN RELATION TO CLINICAL SYMPTOMS AND
PHYSICAL FUNCTION IN ADULTS WITH SYMPTOMATIC KNEE
OSTEOARTHRITIS
A.E. Connelly, A.J. Tucker, L.S. Kott, A.M. Duncan, A.J. Wright. Univ. of
Guelph, Guelph, ON, Canada
Purpose: To date, the majority of osteoarthritis (OA) biomarker
research has examined associations between biomarker levels and
radiographic parameters. While radiography provides information on
the structural burden of disease, it is insensitive to small changes in
cartilage metabolism and does not always correlate with the most
signiﬁcant clinical expression in OA, pain. The purpose of this study was
to investigate the associations between joint metabolism and inﬂam-
mation with pain and physical function in adults with painful knee OA.
This is in support of qualifying burden of disease biomarkers with
clinical variables to support the study, management, and understanding
of disease pathology in OA.
Methods: The study used baseline data from 54 adults with knee OA
participating in a nutrition intervention study. The 100 mm visual
analogue scale version of theWestern Ontario andMcMaster University
Osteoarthritis Index (WOMAC) was used to assess pain, stiffness, and
physical disability. A minimumWOMAC pain score of 125 was used as a
cutoff for participant inclusion. Physical functionwas assessed with a 6-
minute walk test (:6MWT) and stair climb task (SCT). Serum concen-
trations of biomarkers included measures of cartilage degradation
(cartilage oligomeric matrix protein [COMP]), cartilage synthesis (type-
IIA collagen N-propeptide [PIIANP]), synovial metabolism (hyaluronic
acid [HA]), cartilage degrading enzyme levels (matrix metal-
loproteinase 3 [MMP-3]), and inﬂammation (C-reactive protein [CRP]).
COMP, PIIANP, HA, and MMP-3 were measured by enzyme-linked
immunosorbent assay and CRP was measured by an immunoturbidi-
metric assay. Correlations between biomarkers and clinical variables
were assessed using Spearman correlation coefﬁcients.
Results: Participants (38 females and 16 males) had a mean age of 60 
11.9 years, BMI of 32.6  7.5 kg/m2, disease duration of 86.6  112.2
months, and WOMAC pain score of 193.4  94.04 mm. Higher serum
MMP-3 levels were signiﬁcantly associated with higher WOMAC pain
scores (R ¼ 0.27, p ¼ 0.05), controlling for age and body mass index
(BMI). Higher levels of serum HA were signiﬁcantly associated with
decreased walking distance in the :6MWT (R ¼ -0.35, p ¼ 0.01) and
longer time taken in the SCT (R ¼ 0.31, p ¼ 0.02), when controlling for
age and BMI. Higher CRP levels were signiﬁcantly associated with
higher WOMAC physical disability score (R ¼ 0.34, p ¼ 0.01) and worse
performance in the :6MWT (R¼ -0.38, p¼ 0.005) and SCT (R¼ 0.44, p¼
0.001) when age was controlled for, but these associations were not
signiﬁcant when BMI was controlled for. COMP and PIIANP were not
signiﬁcantly associated with any clinical variables analyzed.
Conclusion: SerumMMP-3 levels were associated with pain and serum
HA levels were associated with physical functioning in adults who
suffer from mild to moderate pain and impaired physical functioning
from knee OA. Previous studies have shown that HA and MMP-3 are
related to structural knee parameters in OA. Therefore, results from thisstudy demonstrate that serum HA and MMP-3 also have potential as
qualiﬁed burden of disease biomarkers that are clinically meaningful.
(Research supported by the Ontario Ministry of Agriculture, Food and
Rural Affairs, project #200121).
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FAST FIELD-CYCLING NMR OF CARTILAGE: A WAY TOWARD
MOLECULAR IMAGING
L.M. Broche, B.W. Kennedy, C. MacEachern, G.P. Ashcroft, D.J. Lurie.
Univ. of Aberdeen, Aberdeen, United Kingdom
Purpose: A previous pilot study (presented at OARSI 2012) showed that
Fast Field-Cycling NMR (FFC NMR) can be used to characterise the
dispersion curves of cartilage in the region 0.4 to 3 MHz proton Larmor
frequency. One feature of these dispersion curves, quadrupolar peaks,
arise from relatively well known interactions between water protons
and the 14N nuclei of certain immobilised proteins. We have also pre-
viously shown that osteoarthritic cartilage gives rise to smaller quad-
rupolar peaks than cartilage from healthy volunteers. However, the
exact protein responsible for the quadrupolar peaks observed in carti-
lage samples is uncertain. This present work aims to determine the
protein responsible for the quadrupolar peaks observed in cartilage and
how these signals correlate with disease progression.
Methods: Cartilage samples from femoral heads and knee joints were
obtained after consenting patients undergoing joint replacement sur-
gery or above-knee amputation at NHS Grampian Hospitals. All work
with human tissue was approved by the North of Scotland research
ethic committee. First, a pilot study was conducted on a commercial FFC
NMR scanner (Stelar s.r.l, Mede, Italy). We used a pulse sequence with a
short acquisition time (< 1 ms), and included 7 patients undergoing
arthroplasty for osteoarthritis (OA) and 5 patients undergoing hemi-
arthroplasty for hip fracture. The hip fracture group had no clinical or
radiological evidence of OA prior to the fracture being sustained and
there was no macroscopic evidence of cartilage degeneration seen
intra-operatively on femoral head inspection. In a second, larger study,
we examined the cartilage from 50 patients with evidence of OA
changes and 50without using both long (w20ms) and short acquisition
times.
We also measured the quadrupolar signals from a variety of samples
using both long and short acquisition times including: normal and
osteoarthritic human cartilage; collagen preparations using distilled
water and a commercially available porcine collagen sponge (Colla-
tamp; Tribute pharamaceutical); glycosaminoglycan extracts from
human cartilage (both liquid and lyophilised); and human cartilage
which had been extracted of its glycosaminoglycan (GAG) content with
4M guanidinium chloride.
Results: Variations of the quadrupolar signals were visible between
short (< 1ms) and long (CPMG echo trains, 20 ms) acquisitions. Long
acquisitions did not show any contrast between normal and diseased
cartilagewhereas signiﬁcant differences in quadrupolar peak amplitude
were observed using short acquisition time sequences (3.6 s-1 vs 2.2 s-1,
p < 0.01). We observed no quadrupolar peaks in glycosaminoglycan
extracts from cartilage, whether liquid or lyophilised.
Preparations containing 50%w/w collagen showed quadrupolar peaks
indicating that collagen may be the source of this signal in cartilage.
However, the quadrupolar peaks observed using short acquisition times
were only seen in cartilage which had not been extracted of its GAG
content. This suggests that the quadrupolar peaks observed in cartilage
are likely to be linked to the macromolecular collagen ﬁbril network
and are reduced with decreasing matrix integrity. Interestingly, the
short-lived component of the FFC-NMR signal was not evident in GAG-
extracted cartilage cores from healthy or diseased cartilage. However,
the long-lived signal was unaffected and was not found to be correlated
with OA changes.
Conclusions: GAG extracts of cartilage samples and analysis of collagen
preparations have shown that GAGs are not likely to be the proteins
responsible for quadrupolar peaks. The amide linkages on the backbone
of collagen are therefore indicated as the source of quadrupolar peaks
but the organisation of the macromolecular collagen network within
the cartilage matrix also seems to play an important role in the inter-
action between collagen proteins and water protons.
When this matrix is disturbed, such as after GAG-extraction, the
amplitude of quadrupolar peaks are signiﬁcantly diminished and there
is a loss of the short-lived FFC NMR signal. Therefore it is likely that the
quadrupolar signals of cartilage report on the macromolecular
